獐子島(002069.SZ)上半年預虧2000萬元-4000萬元
格隆匯7月13日丨獐子島(002069.SZ)披露2021年半年度業績預吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤為虧損2000萬元-4000萬元,上年同期為盈利3997.48萬元。
上半年,公司進一步聚焦核心產品和核心區域,做好採購、生產、供應、銷售間的協同,積極運營獐子島海蔘食品和休閒食品,加快“獐子島味道”系列海洋食品市場建設,繼續推進“瘦身”減負,防範和化解各類風險。但新冠疫情和國際貿易形勢對公司產業尤其是進出口業務的影響仍未消除,同時,公司閒置海域放棄及轉讓工作因海域證件撤押及相關政策影響未能如期實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.